A new study finds the combination of excess weight and heart disease in postmenopausal women is associated with an especially high risk of developing breast cancer.
A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.
A new study finds restricting calories or eating low-fat may slightly reduce depressive symptoms, but researchers say the evidence is limited.
In a new study, researchers found no association between treatment with GLP-1 Receptor Agonists like Ozempic and Wegovy and increased risk of adverse psychiatric events.
A new study finds the more ultra-processed foods you eat, the higher your risk of dying prematurely from all causes.
A new study finds diet quality and waist-to-hip ratio strongly impact brain function as you age.
A new study finds people with pockets of fat inside their muscles are at increased risk of hospitalization of death from heart attack.
An international group of medical experts says body mass index is not a reliable way to diagnose obesity. Members of the Commission on Clinical Obesity are recommending new methods that also consider location of excess body fat and objective symptoms of disease.
A new study finds using GLP-1 receptor agonists to treat obesity in otherwise healthy adults is safe and very effective.
U.S. News & World Report, working with leading medical and nutrition experts, reveals a list of the best diets for overall health and specific conditions.
New study examines U.S. trends in body mass index and obesity and finds improving numbers, driven in part by GLP-1 weight-loss drugs.
New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.
A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.
Researchers are now testing a new semaglutide delivery platform that combines the medication with a special hydrogel to achieve sustained release over one month or longer.
Pregnant women with high levels of PFAS chemicals commonly found in consumer products may experience weight and heart issues later in life.
A new study finds overweight people who stay awake too late face higher odds of metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke and diabetes.
A person’s body fat percentage provides a better estimate of their risk for early death than their body mass index (BMI), a new study says.
People with a high body-fat percentage were 78% more likely to die within 15 years from any cause and 3.6 times more likely t...
Fitness trackers aren’t accurately assessing the physical activity of people with obesity, a new study argues.
Differences in walking gait, speed, energy burn and other factors mean that folks with excess weight aren’t getting an accurate read from their devi...
Children born to women who are obese have a higher risk of landing in a hospital with a severe infection, a new study says.
Infants under 1 year of age have a 41% increased risk of hospi...
Being your own boss might seem potentially stressful, but self-employed women appear to have better heart health than those toiling for a company, a new study says.
...